346 related articles for article (PubMed ID: 10772730)
1. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
2. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
3. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
[TBL] [Abstract][Full Text] [Related]
4. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
McKeough MB; Spruance SL
Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
[TBL] [Abstract][Full Text] [Related]
6. [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)].
Chosidow O; Lebrun-Vignes B
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):635-45. PubMed ID: 12122334
[No Abstract] [Full Text] [Related]
7. Short-course therapy for recurrent genital herpes and herpes labialis.
Spruance S; Aoki FY; Tyring S; Stanberry L; Whitley R; Hamed K
J Fam Pract; 2007 Jan; 56(1):30-6. PubMed ID: 17217895
[No Abstract] [Full Text] [Related]
8. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
Kinghorn GR
Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
[TBL] [Abstract][Full Text] [Related]
9. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
10. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230
[TBL] [Abstract][Full Text] [Related]
11. Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir).
Femiano F; Gombos F; Scully C
Oral Dis; 2001 Jan; 7(1):31-3. PubMed ID: 11354919
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
13. Modern management of genital ulcer disease-frappez fort et frappez vite.
Lewis D
Sex Transm Dis; 2010 Aug; 37(8):494-6. PubMed ID: 20539259
[No Abstract] [Full Text] [Related]
14. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
15. A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial.
Chen XS; Han GZ; Guo ZP; Lu NZ; Chen J; Wang JB;
Int J STD AIDS; 2000 Sep; 11(9):568-73. PubMed ID: 10997497
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of acyclovir in the treatment of recurring herpes labialis, genitalis and acute herpes zoster.
Peralta S; Ribisi La Spina AM; Pirrotta P; Collura D; Formica P; Tinnirello D; Citarrella P; Mansueto S
J Chemother; 1989 Jul; 1(4 Suppl):1117-8. PubMed ID: 16312797
[No Abstract] [Full Text] [Related]
17. Topical penciclovir for herpes labialis.
Med Lett Drugs Ther; 1997 Jun; 39(1003):57-8. PubMed ID: 9205430
[No Abstract] [Full Text] [Related]
18. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
[TBL] [Abstract][Full Text] [Related]
20. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]